IGF-I triple helix strategy in hepatoma treatment

Hepato-Gastroenterology

Volumn 48, Issue 39, 2001, Pages 660-666

  Upegui Gonzalez, L C ^a   Ly, A ^a   Sierzega, M ^a   Jarocki, P ^a   Trojan, L ^a   Duc, H T ^a   Pan, Y ^a   Shevelev, A ^a   Henin, D ^a   Anthony, D ^a   Nowak, W ^a   Popiela, T ^a   Trojan, J ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Anti sense; Apoptosis; Hepatocellular carcinoma; IGF I; Triple helix

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIPLE HELIX;

ANIMALS; APOPTOSIS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; RATS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034936888     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cancer of the hepatobiliary system
2. Liver resection versus transplantation for hepatocellular carcinoma cirrhotic patients
3. Current treatment modalities for hepatocellular carcinoma
4. Treatment of hepatocellular carcinoma: Too many options?
5. Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells
6. Gene therapy for hepatoma cells using a retrovirus vector carrying herpex simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter
7. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line
8. Inhibition of alpha-fetoprotein production in a hepatoma cell line by antisense oligonucleotide analogues
9. Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti c-myc DNA phosphorothioate
10. BCR/ABL oncoprotein targeted antitumor activity of antisense oligodeoxynucleotides complementary to M bcr/abl mRNA and herbimycin A an antagonist of protein tyrosine kinase inhibitory effects in vitro growth of Ph 1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells
11. Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes
12. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice
13. Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug resistance gene mdr1 in MDR cancer cells
14. Triplex formation at the rat neu-oncogene promoter
15. Temporary ex vivo inhibition of the expression of the human oncogene HER2 (neu) by a triple helix-forming oligonucleotide
16. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-ki ras promoter
17. Presence of MHC-I and B7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA
18. Increase of interleukin 6 plasma levels after elective craniotomy: Influence of IL-10 and catecholamines
19. Receptors of IL-10 and IL-6 type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements
20. Somatomedine: Proposed designation for sulphation factor
21. Cellular localization of somatomedin (insulin-like growth factor) message RNA in human fetus
22. The insulin-like growth factor I receptor: A key to tumor growth?
23. Rat C6 glial cells synthetsize insulin-like growth factor (IGF-I) and express IGF-I receptors and mannose-6-phosphate receptors
24. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisens cDNA transcription of insulin-like growth factor I
25. Potential triple-helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model
26. Time course development of differentiated hepatocarcinoma and long metastasis in transgenic mice
27. Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice
28. Gene therapy of murine teratocarcinoma: Separate functions for insulin-like growth factors I and II in immunogenicity and differentiation
29. Treatment and prevention of rat glioblastoma by immunogenic C 6 cells expressing antisens insulin-like growth factor I RNA
30. Antisense IGF-I transfer into a rat hepatoma cell line inhibits tumorigenesis by modulating MHC-I
31. Different release of cytokines into cerebrospinal fluid following surgery for intra- and extra-axial brain tumors
32. Glucocorticoid-dependent induction of IL 6 receptor expression in human hepatocytes facilitates IL-6 stimulation of amino acid transport
33. TNF alpha suppress IL-1 alpha and IL-6 upregulation of Cob binding protein in HepG-2 hepatoma cells
34. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells
35. Adenovirus-mediated gene transfer of a human IL-6 antagonist
36. Astrocytes derived cytokines contribute to the metastatic brain specificity of breast cancer cells
37. Subcutaneous vaccination with irradiated cytokine-producing tumor cells stimulates CD 8+ cell mediated immunity against tumors located in the immunologically privileged central nervous system
38. Major histocompatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole and iodide as well as interferon
39. Insulin-like Growth Factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells